Re: [ccp4bb] Off-topic (somewhat): Call for papers on structure-guided kinase drug discovery

2019-11-22 Thread John R Helliwell 
Dear Isabel,
I strongly support and **heartily thankyou** for your email below in support of 
IUCr Journals. A wide range of readerships are covered, now also including 
IUCrJ with its articles describing results aimed at highly diverse readerships 
ie well beyond crystallography. I would also add that the open access fees or 
journal subscription costs are the most competitive ie lowest available. The 
small surpluses from the IUCr Journals that are made are ploughed back into the 
journals further development or support for student conference bursaries and 
community workshops. Contrast that with typically 40 % or more profits made by 
the commercial publishers of research. It is not a given that our community 
IUCr journals will simply just survive. We all need to take responsibility for 
ensuring that they do.
Yours sincerely,
John
Emeritus Professor John R Helliwell DSc
Editor in Chief Acta Cryst and Chairman of the IUCr Journals Commission 1996 to 
2005




> On 22 Nov 2019, at 13:58, Isabel Uson  wrote:
> 
> Dear Julie and Mathew,
> 
> I feel advertisement on behalf of professional publishers is not appropriate 
> for the bulletin board. MDPI should pay for its advertisements, rather than 
> get them for free. (Being a for-profit firm, they should also pay for, rather 
> than invite editing, but this is of course personal). They stand in direct 
> competition with IUCr journals, which it should be in our best interest to 
> protect. We all profit from constant -rather than occasional- scientific 
> editing and the IUCr support to our community (meetings, fellowships, awards).
> I know it is not the first time such a call is posted in the bb and that it 
> is not for me to say what is appropriate or not but I will really miss 
> journals from our scientific societies the day they become extinct.
> Best wishes,
> 
> Isabel
> 
> 
>> On Thu, Nov 21, 2019 at 1:07 AM CCP4BB automatic digest system 
>>  wrote:
>> There are 2 messages totaling 363 lines in this issue.
>> 
>> --
>> 
>> Date:Wed, 20 Nov 2019 17:24:15 +
>> From:Julie Tucker 
>> Subject: Off-topic (somewhat): Call for papers on structure-guided kinase 
>> drug discovery
>> 
>> Dear colleagues,
>> 
>> Mathew Martin and I would very much appreciate your contributions on the
>> topic of "Recent Advances in Structure-Guided Kinase Drug Discovery" for a
>> special issue of the International Journal of Molecular Sciences
>>  (IJMS, ISSN 1422-0067, Current Impact
>> Factor: 4.183). We encourage submission of both *original research articles
>> and topical reviews* on all aspects of *structure-guided drug discovery
>> targeting the phosphotransferase enzyme family*. We welcome accounts of
>> your experiences of applying structure-guided methods of all types to the
>> discovery and development of inhibitors of protein, lipid and small
>> molecule kinases from bacteria to man. More information can be found here:
>> https://www.mdpi.com/journal/ijms/special_issues/structure_guided_kinase.
>> 
>> Due to its open access policy, the journal charges publication fees,
>> however, please contact us directly for the chance to secure a discount on
>> the usual fee. The deadline for submissions is nominally 20th April 2020,
>> however, articles will be peer-reviewed and published on an ongoing basis.
>> 
>> Our apologies to those of you with no interest in kinase drug discovery,
>> and our heartfelt thanks to any of you who feel moved to contact us to
>> discuss potential contributions. Please also feel free to pass this
>> invitation on to any interested colleagues.
>> 
>> Best wishes,
>> Julie Tucker and Mathew Martin
>> -- 
>> Julie Tucker
>> York Biomedical Research Institute
>> Department of Biology and HYMS
>> University of York
>> Heslington
>> YORK
>> YO10 5DD
>> 
>> Tel. 01904 328912
>> 
>> 
>> Co-guest editor of "Recent Advances in Structure-Guided Kinase Drug
>> Discovery
>> "
>> 
>> A special issue of *International Journal of Molecular Sciences*
>>  (IF 4.183) (ISSN 1422-0067).
>> 
>> Email disclaimer
>> 
>> 
>> 
>> 
> 
> 
> -- 
> ICREA Res. Prof. Isabel Usón
> Crystallographic Methods
> Department of Structural Biology (“Maria de Maeztu” Unit of Excellence), 
> Molecular Biology Institute of Barcelona, Spanish Research Council; 
> Barcelona Science Park, Helix Building, 08028 Barcelona (Spain)
> http://chango.ibmb.csic.es/ARCIMBOLDO
> 
> To unsubscribe from the CCP4BB list, click the following link:
> https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB=1



To unsubscribe from the CCP4BB list, click the following link:

Re: [ccp4bb] Off-topic (somewhat): Call for papers on structure-guided kinase drug discovery

2019-11-22 Thread Aaron Finke 
Yes, this issue will definitely compete with IUCr's many journals dedicated to 
kinase drug discovery. /sarcasm

On a more serious note: nobody should be "loyal" to a journal or scientific 
society; both are servants of the scientific community, not the other way 
around. If they stop supporting scientists with their roles and policies, those 
scientists will move elsewhere (note, for example, the American 
Crystallographic Association and the diaspora of structural biologists/protein 
crystallographers from the ACA). If I submit to an IUCr journal, it is because 
my work is geared toward the community of IUCr journal readers. IUCr journals 
are not always going to attract the right audience for a particular study, and 
that's fine. Not everyone here is a capital-C Crystallographer, and if someone 
in this community wants to bring to our attention an opportunity that may 
benefit its users, that's great! I take issue with MDPI's policies as a 
publishing house, but guest editors posting about a special issue on behalf of 
them is more beneifical than harmful.

In that vein, advertistments for job postings are professionally-related and 
also not relevant to CCP4 but I think everyone, especially young scientists, 
benefit from those as well.

Aaron
--
Aaron Finke
Staff Scientist, MacCHESS
Cornell University
e-mail: af...@cornell.edu

On Nov 22, 2019, at 8:58 AM, Isabel Uson 
mailto:iuf...@ibmb.csic.es>> wrote:

Dear Julie and Mathew,

I feel advertisement on behalf of professional publishers is not appropriate 
for the bulletin board. MDPI should pay for its advertisements, rather than get 
them for free. (Being a for-profit firm, they should also pay for, rather than 
invite editing, but this is of course personal). They stand in direct 
competition with IUCr journals, which it should be in our best interest to 
protect. We all profit from constant -rather than occasional- scientific 
editing and the IUCr support to our community (meetings, fellowships, awards).
I know it is not the first time such a call is posted in the bb and that it is 
not for me to say what is appropriate or not but I will really miss journals 
from our scientific societies the day they become extinct.
Best wishes,

Isabel


On Thu, Nov 21, 2019 at 1:07 AM CCP4BB automatic digest system 
mailto:lists...@jiscmail.ac.uk>> wrote:
There are 2 messages totaling 363 lines in this issue.

--

Date:Wed, 20 Nov 2019 17:24:15 +
From:Julie Tucker mailto:julie.tuc...@york.ac.uk>>
Subject: Off-topic (somewhat): Call for papers on structure-guided kinase drug 
discovery

Dear colleagues,

Mathew Martin and I would very much appreciate your contributions on the
topic of "Recent Advances in Structure-Guided Kinase Drug Discovery" for a
special issue of the International Journal of Molecular Sciences
 (IJMS, ISSN 1422-0067, Current Impact
Factor: 4.183). We encourage submission of both *original research articles
and topical reviews* on all aspects of *structure-guided drug discovery
targeting the phosphotransferase enzyme family*. We welcome accounts of
your experiences of applying structure-guided methods of all types to the
discovery and development of inhibitors of protein, lipid and small
molecule kinases from bacteria to man. More information can be found here:
https://www.mdpi.com/journal/ijms/special_issues/structure_guided_kinase.

Due to its open access policy, the journal charges publication fees,
however, please contact us directly for the chance to secure a discount on
the usual fee. The deadline for submissions is nominally 20th April 2020,
however, articles will be peer-reviewed and published on an ongoing basis.

Our apologies to those of you with no interest in kinase drug discovery,
and our heartfelt thanks to any of you who feel moved to contact us to
discuss potential contributions. Please also feel free to pass this
invitation on to any interested colleagues.

Best wishes,
Julie Tucker and Mathew Martin
--
Julie Tucker
York Biomedical Research Institute
Department of Biology and HYMS
University of York
Heslington
YORK
YO10 5DD

Tel. 01904 328912


Co-guest editor of "Recent Advances in Structure-Guided Kinase Drug
Discovery
"

A special issue of *International Journal of Molecular Sciences*
 (IF 4.183) (ISSN 1422-0067).

Email disclaimer





--
ICREA Res. Prof. Isabel Usón
Crystallographic Methods
Department of Structural Biology (“Maria de Maeztu” Unit of Excellence),
Molecular Biology Institute of Barcelona, Spanish Research Council;
Barcelona Science Park, Helix Building, 08028 Barcelona (Spain)

Re: [ccp4bb] Off-topic (somewhat): Call for papers on structure-guided kinase drug discovery

2019-11-22 Thread Isabel Uson 
Dear Julie and Mathew,

I feel advertisement on behalf of professional publishers is not
appropriate for the bulletin board. MDPI should pay for its advertisements,
rather than get them for free. (Being a for-profit firm, they should also
pay for, rather than invite editing, but this is of course personal). They
stand in direct competition with IUCr journals, which it should be in our
best interest to protect. We all profit from constant -rather than
occasional- scientific editing and the IUCr support to our community
(meetings, fellowships, awards).
I know it is not the first time such a call is posted in the bb and that it
is not for me to say what is appropriate or not but I will really miss
journals from our scientific societies the day they become extinct.
Best wishes,

Isabel


On Thu, Nov 21, 2019 at 1:07 AM CCP4BB automatic digest system <
lists...@jiscmail.ac.uk> wrote:

> There are 2 messages totaling 363 lines in this issue.
>
> --
>
> Date:Wed, 20 Nov 2019 17:24:15 +
> From:Julie Tucker 
> Subject: Off-topic (somewhat): Call for papers on structure-guided kinase
> drug discovery
>
> Dear colleagues,
>
> Mathew Martin and I would very much appreciate your contributions on the
> topic of "Recent Advances in Structure-Guided Kinase Drug Discovery" for a
> special issue of the International Journal of Molecular Sciences
>  (IJMS, ISSN 1422-0067, Current Impact
> Factor: 4.183). We encourage submission of both *original research articles
> and topical reviews* on all aspects of *structure-guided drug discovery
> targeting the phosphotransferase enzyme family*. We welcome accounts of
> your experiences of applying structure-guided methods of all types to the
> discovery and development of inhibitors of protein, lipid and small
> molecule kinases from bacteria to man. More information can be found here:
> https://www.mdpi.com/journal/ijms/special_issues/structure_guided_kinase.
>
> Due to its open access policy, the journal charges publication fees,
> however, please contact us directly for the chance to secure a discount on
> the usual fee. The deadline for submissions is nominally 20th April 2020,
> however, articles will be peer-reviewed and published on an ongoing basis.
>
> Our apologies to those of you with no interest in kinase drug discovery,
> and our heartfelt thanks to any of you who feel moved to contact us to
> discuss potential contributions. Please also feel free to pass this
> invitation on to any interested colleagues.
>
> Best wishes,
> Julie Tucker and Mathew Martin
> --
> Julie Tucker
> York Biomedical Research Institute
> Department of Biology and HYMS
> University of York
> Heslington
> YORK
> YO10 5DD
>
> Tel. 01904 328912
>
>
> Co-guest editor of "Recent Advances in Structure-Guided Kinase Drug
> Discovery
>  >"
>
> A special issue of *International Journal of Molecular Sciences*
>  (IF 4.183) (ISSN 1422-0067).
>
> Email disclaimer
> 
>
> 
>
>
-- 
ICREA Res. Prof. Isabel Usón
Crystallographic Methods
Department of Structural Biology (“Maria de Maeztu” Unit of Excellence),
Molecular Biology Institute of Barcelona, Spanish Research Council;
Barcelona Science Park, Helix Building, 08028 Barcelona (Spain)
http://chango.ibmb.csic.es/ARCIMBOLDO



To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB=1

[ccp4bb] Off-topic (somewhat): Call for papers on structure-guided kinase drug discovery

2019-11-20 Thread Julie Tucker 
Dear colleagues,

Mathew Martin and I would very much appreciate your contributions on the
topic of "Recent Advances in Structure-Guided Kinase Drug Discovery" for a
special issue of the International Journal of Molecular Sciences
 (IJMS, ISSN 1422-0067, Current Impact
Factor: 4.183). We encourage submission of both *original research articles
and topical reviews* on all aspects of *structure-guided drug discovery
targeting the phosphotransferase enzyme family*. We welcome accounts of
your experiences of applying structure-guided methods of all types to the
discovery and development of inhibitors of protein, lipid and small
molecule kinases from bacteria to man. More information can be found here:
https://www.mdpi.com/journal/ijms/special_issues/structure_guided_kinase.

Due to its open access policy, the journal charges publication fees,
however, please contact us directly for the chance to secure a discount on
the usual fee. The deadline for submissions is nominally 20th April 2020,
however, articles will be peer-reviewed and published on an ongoing basis.

Our apologies to those of you with no interest in kinase drug discovery,
and our heartfelt thanks to any of you who feel moved to contact us to
discuss potential contributions. Please also feel free to pass this
invitation on to any interested colleagues.

Best wishes,
Julie Tucker and Mathew Martin
-- 
Julie Tucker
York Biomedical Research Institute
Department of Biology and HYMS
University of York
Heslington
YORK
YO10 5DD

Tel. 01904 328912


Co-guest editor of "Recent Advances in Structure-Guided Kinase Drug
Discovery
"

A special issue of *International Journal of Molecular Sciences*
 (IF 4.183) (ISSN 1422-0067).

Email disclaimer




To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB=1